Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson’s Disease

• Satoru Hasegawa,

  Affiliations Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan, Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan

  ⨯
• Sae Goto,

  Affiliation Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan

  ⨯
• Hirokazu Tsuji,

  Affiliation Yakult Central Institute, Tokyo, Japan

  ⨯
• Tatsuya Okuno,

  Affiliation Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan

  ⨯
• Takashi Asahara,

  Affiliation Yakult Central Institute, Tokyo, Japan

  ⨯
• Koji Nomoto,

  Affiliation Yakult Central Institute, Tokyo, Japan

  ⨯
• Akihide Shibata,

  Affiliation Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan

  ⨯
• Yoshiro Fujisawa,

  Affiliation Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan

  ⨯
• Tomomi Minato,

  Affiliation Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan

  ⨯
• Akira Okamoto,

  Affiliation Department of School Health Sciences, Aichi University of Education, Kariya, Japan

  ⨯
• Kinji Ohno ,

  * E-mail: hirasan@met.nagoya-u.ac.jp (MH); ohnok@med.nagoya-u.ac.jp (KO)

  Affiliation Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan

  ⨯
• Masaaki Hirayama

  * E-mail: hirasan@met.nagoya-u.ac.jp (MH); ohnok@med.nagoya-u.ac.jp (KO)

  Affiliation Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan

  ⨯